buspirone has been researched along with Kidney Failure in 1 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Kidney Failure: A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Buspirone is an anxiolytic drug given at a dosage of 15 mg/day." | 2.40 | Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug. ( Mahmood, I; Sahajwalla, C, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahmood, I | 1 |
| Sahajwalla, C | 1 |
1 review available for buspirone and Kidney Failure
| Article | Year |
|---|---|
Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug.
Topics: Aged; Anti-Anxiety Agents; Area Under Curve; Buspirone; Clinical Trials as Topic; Cross-Over Studies | 1999 |